Get the Stockscreener App
36.00
4.90%
1.68
After Hours:
36.00
Omnicell Inc stock is traded at $36.00, with a volume of 529.87K.
It is up +4.90% in the last 24 hours and up +16.20% over the past month.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
See More
Previous Close:
$34.32
Open:
$34.41
24h Volume:
529.87K
Relative Volume:
1.19
Market Cap:
$1.62B
Revenue:
$1.15B
Net Income/Loss:
$23.09M
P/E Ratio:
72.00
EPS:
0.5
Net Cash Flow:
$89.18M
1W Performance:
+2.51%
1M Performance:
+16.20%
6M Performance:
+31.68%
1Y Performance:
-18.39%
1-Day Range:
$34.38
$36.84
1-Week Range:
$33.25
$36.84
52-Week Range:
$22.66
$48.67
Omnicell Inc Stock (OMCL) Company Profile
Name
Omnicell Inc
Sector
Industry
Phone
(877) 415-9990
Address
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
36.00 | 1.54B | 1.15B | 23.09M | 89.18M | 0.50 |
|
VEEV
Veeva Systems Inc
|
244.06 | 44.34B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
70.29 | 11.69B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
101.91 | 8.68B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
50.42 | 8.74B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
35.74 | 6.66B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-14-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-31-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-02-24 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-03-24 | Initiated | Barclays | Underweight |
| Nov-03-23 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-03-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Nov-03-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-11-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-26-23 | Reiterated | Wells Fargo | Underweight |
| Aug-02-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-20-23 | Downgrade | Wells Fargo | Overweight → Underweight |
| Feb-27-23 | Upgrade | The Benchmark Company | Hold → Buy |
| Nov-03-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-09-22 | Initiated | BofA Securities | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Mkt Perform |
| Dec-06-21 | Resumed | Wells Fargo | Overweight |
| Jun-09-21 | Initiated | JP Morgan | Neutral |
| May-24-21 | Initiated | BTIG Research | Buy |
| Feb-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Dec-03-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Feb-07-20 | Reiterated | Dougherty & Company | Buy |
| Nov-21-19 | Reiterated | Dougherty & Company | Buy |
| Jul-26-19 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-07-19 | Reiterated | Dougherty & Company | Buy |
| Jun-29-18 | Resumed | The Benchmark Company | Buy |
| Sep-05-17 | Reiterated | The Benchmark Company | Buy |
| Jul-28-17 | Reiterated | Dougherty & Company | Buy |
| Apr-21-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-19-17 | Initiated | Dougherty & Company | Buy |
| Dec-06-16 | Reiterated | The Benchmark Company | Buy |
| Jul-07-16 | Reiterated | FBR Capital | Outperform |
| Mar-21-16 | Reiterated | Topeka Capital Markets | Buy |
| Jan-07-16 | Initiated | The Benchmark Company | Buy |
| Nov-16-15 | Reiterated | Topeka Capital Markets | Buy |
| Oct-30-15 | Reiterated | FBR Capital | Outperform |
| Sep-28-15 | Upgrade | Sidoti | Neutral → Buy |
| Jul-31-15 | Reiterated | Topeka Capital Markets | Buy |
View All
Omnicell Inc Stock (OMCL) Latest News
How Omnicell Inc. (OC9) stock moves in volatile trading sessions2025 Technical Overview & Verified Trade Idea Suggestions - newser.com
Can Omnicell Inc. (OC9) stock deliver consistent EPS growthGlobal Markets & Risk Managed Investment Signals - newser.com
Omnicell to Present at the Piper Sandler 37th Annual Healthcare Conference - The Joplin Globe
Is Omnicell Inc. stock attractive after correctionQuarterly Trade Review & Free Low Drawdown Momentum Trade Ideas - newser.com
How Omnicell Inc. (OC9) stock reacts to new regulationsWeekly Profit Report & Verified Entry Point Detection - newser.com
Will Omnicell Inc. (OC9) stock keep raising dividendsJuly 2025 Drop Watch & Weekly Watchlist for Consistent Profits - newser.com
Smart Storage Cabinet Market Set for Dynamic Growth with Key Players Omnicell Inc., BD Pyxis, SupplyPoint Systems - openPR.com
How reliable is Omnicell Inc. (OC9) stock dividend growthJuly 2025 PreEarnings & Weekly High Momentum Picks - newser.com
Can Omnicell Inc. (OC9) stock double in coming years2025 Year in Review & Smart Allocation Stock Reports - newser.com
Is Omnicell Inc. stock a buy for dividend growthSwing Trade & Verified Chart Pattern Trade Signals - newser.com
Will Omnicell Inc. (OC9) stock sustain dividend payouts2025 Big Picture & Verified Entry Point Signals - newser.com
Will Omnicell Inc. (OC9) stock deliver stable dividendsWeekly Risk Summary & Daily Technical Forecast Reports - newser.com
How resilient is Omnicell Inc. stock in market downturnsPortfolio Update Report & Weekly High Conviction Trade Ideas - newser.com
Will Omnicell Inc. stock sustain high P E ratios2025 Short Interest & Long-Term Safe Investment Plans - newser.com
The Five-year Shareholder Returns and Company Earnings Persist Lower as Omnicell (NASDAQ:OMCL) Stock Falls a Further 7.1% in Past Week - 富途牛牛
What Wall Street predicts for Omnicell Inc. stock priceGlobal Markets & Technical Buy Zone Confirmations - newser.com
Automated trading signals detected on Omnicell Inc.Wall Street Watch & Verified Momentum Watchlists - newser.com
Omnicell Inc Stock (OMCL) Financials Data
Revenue
Net Income
Cash Flow
EPS
11.42%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):